| Detected | Trial | Change |
|---|---|---|
| 2026-06-09 | NCT07318558 A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer… |
Trial sites expanded: 77 -> 89 locations |
| 2026-06-09 | NCT07419295 A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer… |
Trial sites expanded: 42 -> 50 locations |
| 2026-06-09 | NCT07185997 Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's… |
Trial sites expanded: 62 -> 74 locations |
| 2026-06-09 | NCT07216703 A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab… |
Trial sites expanded: 115 -> 125 locations |
| 2026-06-06 | NCT07007559 ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in… |
Trial sites expanded: 32 -> 44 locations |
| 2026-06-02 | NCT07341100 Study to Evaluate the Preliminary Efficacy of SKB264 and the Effect of Clarithromycin on… |
overall status: "Recruiting" → "Active Not Recruiting" |
| 2026-06-02 | NCT07216703 A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab… |
Trial sites expanded: 107 -> 115 locations |
| 2026-05-30 | NCT06393374 Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not… |
Trial sites expanded: 293 -> 297 locations |
| 2026-05-30 | NCT07419295 A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer… |
Trial sites expanded: 38 -> 42 locations |
| 2026-05-30 | NCT07318558 A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer… |
Trial sites expanded: 60 -> 77 locations |
| 2026-05-28 | NCT06459180 A Study to Compare Sacituzumab Tirumotecan (MK-2870) Monotherapy Versus Treatment of… |
overall status: "Recruiting" → "Active Not Recruiting" |
| 2026-05-28 | NCT04345913 Testing the Addition of Copanlisib to Eribulin in Metastatic Triple Negative Breast Cancer |
date change Completion pushed: 2026-05-07 -> 2027-05-31 |
| 2026-05-27 | NCT07286149 A Clinical Study of MK-1084 With Other Treatments for Non-small Cell Lung Cancer… |
Trial sites expanded: 12 -> 18 locations |
| 2026-05-27 | NCT07461454 YL202 Versus Treatment of Physician's Choice in Patients With HR+/HER2- Breast Cancer |
Recruitment opened |
| 2026-05-23 | NCT07419295 A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer… |
Trial sites expanded: 30 -> 38 locations |
| 2026-05-23 | NCT06966700 A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast… |
Trial sites expanded: 287 -> 291 locations |
| 2026-05-23 | NCT06305754 Sacituzumab Tirumotecan (MK-2870) Versus Pemetrexed and Carboplatin Combination Therapy… |
overall status: "Recruiting" → "Active Not Recruiting" |
| 2026-05-23 | NCT07318558 A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer… |
Trial sites expanded: 50 -> 60 locations |
| 2026-05-23 | NCT07173751 ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative… |
Trial sites expanded: 83 -> 104 locations |
| 2026-05-23 | NCT07216703 A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab… |
Trial sites expanded: 96 -> 107 locations |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-06-10 | NCT07639086 Sacituzumab Tirumotecan in Pts w/ NEPC After Progression on Prior Chemotherapy | Phase 2 | Not Yet Recruiting |
| 2026-06-05 | NCT07628504 Sac-TMT Sequential Capecitabine Versus Capecitabine in Early-Stage High-Risk… | Phase 3 | Not Yet Recruiting |
| 2026-06-03 | NCT07622186 A Study of SKB571 Combination Therapy in Participants With Non-Small Cell Lung Cancer… | Phase 2 | Not Yet Recruiting |
| 2026-06-03 | NCT07622706 Firmonertinib in Perioperative Treatment of Resectable Stage II-IIIB EGFR-mutated Lung… | Phase 2 | Not Yet Recruiting |
| 2026-06-03 | NCT07623577 Sac-TMT Combined With Bevacizumab in TNBC With Brain Metastases | Phase 2 | Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT06711900 | A Study of SKB264 in Combination With Pembrolizumab Versus Chemotherapy in Combination… | Non-Small Cell Lung Cancer | Recruiting |
| NCT06435429 | A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in… | Metastatic HER2-positive Breast Cancer | Recruiting |
| NCT06081959 | Study of SKB264 for Locally Advanced, Recurrent or Metastatic HR+/HER2- Breast Cancer | Metastatic Breast Cancer | Recruiting |
| NCT06279364 | A Study of SKB264 Versus Investigator's Choice Chemotherapy in Patients With Unresectable… | Triple Negative Breast Cancer | Recruiting |
| NCT06670196 | A Study of SKB264 in Combination With Osimertinib Versus Osimertinib in Patients With… | Non-Small Cell Lung Cancer | Recruiting |
| NCT07071337 | A Study of SKB264 Versus Investigator's Choice of Chemotherapy in Subjects With… | Metastatic Breast Cancer | Recruiting |
| NCT06312137 | A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab… | Non Small Cell Lung Cancer | Recruiting |
| NCT07173751 | ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative… | Breast Neoplasms | Recruiting |
| NCT07461454 | YL202 Versus Treatment of Physician's Choice in Patients With HR+/HER2- Breast Cancer | Locally Advanced or Metastatic Breast Cancer | Recruiting |
| NCT06841354 | A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination… | Triple Negative Breast Neoplasms | Recruiting |
| NCT06952504 | A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab… | Endometrial Cancer | Recruiting |
| NCT06170788 | Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab… | Non-small Cell Lung Cancer (NSCLC) | Recruiting |
| NCT06312176 | A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With… | Breast Neoplasms | Recruiting |
| NCT06393374 | Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not… | Triple-Negative Breast Cancer | Recruiting |
| NCT06422143 | Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in… | Non-small Cell Lung Cancer | Recruiting |
| NCT06824467 | A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870)… | Ovarian Cancer | Recruiting |
| NCT06966700 | A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast… | Breast Neoplasms | Recruiting |
| NCT07185997 | Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's… | Non-Small-Cell Lung Cancer | Recruiting |
| NCT07216703 | A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab… | Cervical Cancer | Recruiting |
| NCT07318558 | A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer… | Ovarian Neoplasms | Recruiting |
| NCT07419295 | A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer… | Bladder Cancer | Recruiting |
| NCT06519370 | FDA018-ADC vs Investigator's Choice Chemotherapy to Treat Locally Advanced, Recurrent or… | Triple Negative Breast Cancer | Active, Not Recruiting |
| NCT04639986 | Asian Study of Sacituzumab Govitecan (IMMU-132) in HR+/HER2- Metastatic Breast Cancer… | Metastatic Breast Cancer | Active, Not Recruiting |
| NCT06356311 | A Study to Evaluate Sacituzumab Tirumotecan (MK-2870) in Advanced/Metastatic… | Gastroesophageal Cancer | Active, Not Recruiting |
| NCT06132958 | Sacituzumab Tirumotecan (MK-2870) in Post Platinum and Post Immunotherapy Endometrial… | Endometrial Cancer | Active, Not Recruiting |